Cargando…

Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)

BACKGROUND: We tested the association of colon tumour sidedness with prognosis and with molecular subtypes recently shown to be predictive of oxaliplatin benefit in stage III colon cancer. METHODS: NSABP/NRG C-07 trial (N=1603) was used to determine association of tumour sidedness with molecular sub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, S Rim, Song, Nan, Yothers, Greg, Gavin, Patrick G, Allegra, Carmen J, Paik, Soonmyung, Pogue-Geile, Katherine L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846062/ https://www.ncbi.nlm.nih.gov/pubmed/29241223 http://dx.doi.org/10.1038/bjc.2017.448

Ejemplares similares

Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831
por: Pogue-Geile, Katherine L, et al.
Publicado: (2020)

Health‐related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R‐04
por: Ganz, Patricia A., et al.
Publicado: (2022)

Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30
por: Henry, N. Lynn, et al.
Publicado: (2022)

Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35
por: Henry, N. Lynn, et al.
Publicado: (2021)

Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial
por: Advani, Pooja P., et al.
Publicado: (2023)

NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab
por: Ganz, Patricia A., et al.
Publicado: (2021)

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2(+) breast cancer
por: Jacobs, Samuel A., et al.
Publicado: (2019)

Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
por: Jacobs, Samuel A., et al.
Publicado: (2020)

Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations
por: Pal, Rekha, et al.
Publicado: (2018)

Talking numbers: how women and providers use risk scores during and after risk counseling – a qualitative investigation from the NRG Oncology/NSABP DMP-1 study
por: Blakeslee, Sarah B, et al.
Publicado: (2023)

A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes
por: Fumagalli, Debora, et al.
Publicado: (2010)

Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10
por: Abraham, Jame, et al.
Publicado: (2019)

Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination
por: Swain, Sandra M., et al.
Publicado: (2019)

Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial
por: Calsavara, Vinicius F., et al.
Publicado: (2023)

Oncological impact of vascular invasion in colon cancer might differ depending on tumor sidedness
por: Shalkamy, Moamen Shalkamy Abdelgawaad, et al.
Publicado: (2022)

Evaluation of three APBI techniques under NSABP B‐39 guidelines
por: Scanderbeg, Daniel, et al.
Publicado: (2009)

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study
por: Seamon, Leigh G, et al.
Publicado: (2018)

Primary chemotherapy for operable breast cancer: the NSABP experience
por: Bear, HD
Publicado: (2005)

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials
por: Hallemeier, Christopher L., et al.
Publicado: (2023)

An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier
por: Seo, Mi-kyoung, et al.
Publicado: (2020)

Impact of sidedness of colorectal cancer on tumor immunity
por: Takasu, Chie, et al.
Publicado: (2020)

Plant cell polarity: The many facets of sidedness
por: Dong, Juan, et al.
Publicado: (2023)

NRG Oncology Survey on Practice and Technology Use in SRT and SBRT Delivery
por: Chetvertkov, Mikhail, et al.
Publicado: (2020)

Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status
por: Refaat, Bassem, et al.
Publicado: (2021)

Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials
por: George, Thomas J., et al.
Publicado: (2015)

Colon Cancer Sidedness, Presentation, and Survival at Different Stages
por: Ulanja, Mark B., et al.
Publicado: (2019)

“Sidedness” as a standard hypernym for “right” and “left” in anatomy
por: Amarin, Justin Z., et al.
Publicado: (2021)

Recruitment practices for U.S. minority and underserved populations in NRG oncology: Results of an online survey()
por: Cook, Elise D., et al.
Publicado: (2018)

Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness
por: Refaat, Bassem, et al.
Publicado: (2023)

Is the Severity of Cervical Foraminal Stenosis Related to the Severity and Sidedness of Symptoms?
por: Lee, Han-Dong, et al.
Publicado: (2021)

Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology
por: Gensheimer, Michael F., et al.
Publicado: (2020)

NRG Oncology Survey of Monte Carlo Dose Calculation Use in US Proton Therapy Centers
por: Lin, Liyong, et al.
Publicado: (2021)

Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
por: Yom, Sue S., et al.
Publicado: (2021)

Effects of RET, NRG1 and NRG3 Polymorphisms in a Chinese Population with Hirschsprung Disease
por: Yang, Dehua, et al.
Publicado: (2017)

Laterality and Left-sidedness in the Nose, Face, and Body: A New Finding
por: Hafezi, Farhad, et al.
Publicado: (2017)

Prognostic effect of sidedness in early stage versus advanced colon cancer
por: Kennecke, H.F., et al.
Publicado: (2018)

Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients
por: Brungs, Daniel, et al.
Publicado: (2017)

Impact of tumor sidedness on survival and recurrence patterns in colon cancer patients
por: Lee, Jong Min, et al.
Publicado: (2019)

Sidedness determines clinical characteristics and survival outcomes in medullary adenocarcinoma of the colon
por: Blakely, Andrew M., et al.
Publicado: (2021)

Perceived sidedness and correlation to vertical movement asymmetries in young warmblood horses
por: Leclercq, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bm3737lric0t200r2clounsleq